Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$2.37M
4 trades · 2 insiders
Net · 90d
$-2.37M
Insiders on file
25
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| PERRY MICHAEL S | Director | 43 | $0 | $10.34M | 2026-08-18 |
| OLUKOTUN ADEOYE Y | Director | 20 | $0 | $2.05M | 2026-08-18 |
| Cohen Matthew Gregory | Director | 1 | $0 | $0 | 2026-06-15 |
| Lu Hongbo | Director | 6 | $83.0K | $228.3K | 2026-05-12 |
| Hamilton James C | Other | 62 | $0 | $14.39M | 2026-04-23 |
| Apel Daniel Joseph | Chief Financial Officer | 4 | $0 | $934.3K | 2026-04-22 |
| O'Brien Patrick | General Counsel | 80 | $0 | $20.67M | 2026-01-06 |
| Anzalone Christopher Richard | President and CEO | 185 | $202.2K | $108.95M | 2026-01-02 |
| Ferrari Mauro | Director | 22 | $14.8K | $2.34M | 2025-12-26 |
| Vakiener Victoria | Director | 14 | $0 | $1.14M | 2025-12-19 |
| Waddill William D. | Director | 26 | $0 | $2.84M | 2025-12-19 |
| INGRAM DOUGLAS S | Director | 2 | $0 | $0 | 2025-12-16 |
| Myszkowski Kenneth Allen | Chief Financial Officer | 125 | $0 | $24.54M | 2025-01-07 |
| GIVEN DOUGLAS B | Director | 69 | $43.5K | $5.36M | 2024-12-17 |
| Oliver Tracie | Chief Commercial Officer | 5 | $0 | $555.1K | 2024-07-02 |
| San Martin Javier | Chief Medical Officer | 13 | $0 | $4.15M | 2024-01-05 |
| De Backer Marianne | Director | 19 | $184.7K | $740.4K | 2023-01-10 |
| Hassard James | Chief Commercial Officer | 2 | $0 | $1.50M | 2021-06-22 |
| Bradshaw Curt | Chief Scientific Officer | 2 | $0 | $2.16M | 2020-11-20 |
| GIVEN BRUCE D | Chief Operating Officer | 87 | $0 | $14.16M | 2020-04-28 |
| Li Zhen | Snr. VP, Chem and Non-Clin Dev | 2 | $0 | $580.8K | 2019-01-14 |
| Leone Peter Brian | VP, Strategy & Program Mgmt | 10 | $0 | $1.77M | 2018-10-19 |
| FRYKMAN EDWARD W | Director | 14 | $0 | $50.3K | 2018-01-01 |
| Lewis David L. | Chief Scientific Officer | 16 | $0 | $499.8K | 2016-01-01 |
| McKenney Charles | Director | 16 | $0 | $351.8K | 2015-03-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| PERRY MICHAEL S | Director | S Sale | 2026-08-18 | 2026-08-20 | 11,600 | $87.30 | $1.01M | 111,459 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2026-08-18 | 2026-08-20 | 2,000 | $86.96 | $173.9K | 31,600 | SEC↗ |
| PERRY MICHAEL S | Director | S Sale | 2026-08-18 | 2026-08-20 | 11,600 | $87.30 | $1.01M | 111,459 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2026-08-18 | 2026-08-20 | 2,000 | $86.96 | $173.9K | 31,600 | SEC↗ |
| Cohen Matthew Gregory | Director | A Award | 2026-06-15 | 2026-06-17 | 11,882 | — | $0 | 11,882 | SEC↗ |
| Lu Hongbo | Director | S Sale | 2026-05-12 | 2026-05-14 | 2,970 | $76.88 | $228.3K | 52,012 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-04-23 | 2026-04-24 | 10,000 | $75.00 | $750.0K | 226,958 | SEC↗ |
| Apel Daniel Joseph | Chief Financial Officer | S Sale | 2026-04-22 | 2026-04-24 | 3,208 | $70.11 | $224.9K | 172,792 | SEC↗ |
| Apel Daniel Joseph | Chief Financial Officer | S Sale | 2026-04-22 | 2026-04-24 | 1,157 | $70.45 | $81.5K | 171,635 | SEC↗ |
| Apel Daniel Joseph | Chief Financial Officer | S Sale | 2026-04-22 | 2026-04-24 | 8,730 | $71.92 | $627.9K | 162,905 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-03-05 | 2026-03-09 | 10,000 | $64.19 | $641.9K | 236,958 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2026-01-06 | 2026-01-08 | 440 | — | $0 | 472,848 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2026-01-06 | 2026-01-08 | 540 | — | $0 | 474,368 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2026-01-06 | 2026-01-08 | 540 | — | $0 | 473,828 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2026-01-06 | 2026-01-08 | 440 | — | $0 | 472,408 | SEC↗ |
| O'Brien Patrick | COO | A Award | 2026-01-06 | 2026-01-08 | 75,000 | — | $0 | 547,408 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2026-01-06 | 2026-01-08 | 540 | — | $0 | 473,288 | SEC↗ |
| Apel Daniel Joseph | Chief Financial Officer | A Award | 2026-01-06 | 2026-01-08 | 75,000 | — | $0 | 176,200 | SEC↗ |
| Hamilton James C | Chief Medical Officer | A Award | 2026-01-06 | 2026-01-08 | 75,000 | — | $0 | 246,958 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 12,711 | $63.95 | $812.9K | 173,904 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 437 | $65.97 | $28.8K | 172,267 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 1,200 | $64.49 | $77.4K | 172,704 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 309 | $68.00 | $21.0K | 171,958 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 14,792 | $63.01 | $932.0K | 186,615 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 6,090 | $62.28 | $379.3K | 201,407 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-05 | 4,625 | $61.24 | $283.2K | 207,497 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 2,336 | $64.04 | $149.6K | 474,954 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 5,873 | $62.91 | $369.5K | 477,290 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 900 | $62.25 | $56.0K | 483,163 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 600 | $61.12 | $36.7K | 484,063 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 313 | $68.00 | $21.3K | 484,663 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 900 | $66.01 | $59.4K | 484,976 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 2,700 | $64.44 | $174.0K | 485,876 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 11,842 | $63.84 | $756.0K | 488,576 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 13,451 | $62.96 | $846.9K | 500,418 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 6,164 | $62.23 | $383.6K | 513,869 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 4,368 | $61.20 | $267.3K | 520,033 | SEC↗ |
| O'Brien Patrick | COO | S Sale | 2026-01-05 | 2026-01-05 | 46 | $68.00 | $3.1K | 474,908 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2026-01-02 | 2026-01-05 | 7,416 | $65.88 | $488.6K | 3,798,510 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2026-01-02 | 2026-01-05 | 5,771 | $66.39 | $383.1K | 3,792,739 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2025-12-31 | 2026-01-05 | 560 | — | $0 | 526,081 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2025-12-31 | 2026-01-05 | 560 | — | $0 | 524,401 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2025-12-31 | 2026-01-05 | 560 | — | $0 | 524,961 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2025-12-31 | 2026-01-05 | 560 | — | $0 | 525,521 | SEC↗ |
| O'Brien Patrick | COO | G Gift | 2025-12-31 | 2026-01-05 | 560 | — | $0 | 526,641 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2025-12-29 | 2025-12-30 | 35,181 | — | $0 | 16,545 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2025-12-29 | 2025-12-30 | 16,545 | — | $0 | 0 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2025-12-29 | 2025-12-30 | 35,181 | $6.15 | $216.4K | 3,841,107 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2025-12-29 | 2025-12-30 | 16,545 | $6.15 | $101.8K | 3,857,652 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-29 | 2025-12-30 | 35,181 | $69.33 | $2.44M | 3,822,471 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-29 | 2025-12-30 | 16,545 | $68.69 | $1.14M | 3,805,926 | SEC↗ |
| Ferrari Mauro | Director | S Sale | 2025-12-26 | 2025-12-30 | 7,530 | $70.00 | $527.1K | 69,053 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-22 | 2025-12-23 | 10,012 | $68.33 | $684.1K | 3,808,500 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-22 | 2025-12-23 | 2,574 | $68.85 | $177.2K | 3,805,926 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2025-12-19 | 2025-12-23 | 827 | $68.48 | $56.6K | 33,600 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2025-12-19 | 2025-12-23 | 6,083 | $68.04 | $413.9K | 34,427 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2025-12-19 | 2025-12-23 | 3,090 | $66.70 | $206.1K | 40,510 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-19 | 2025-12-23 | 1,319 | $68.48 | $90.3K | 3,818,512 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-19 | 2025-12-23 | 8,147 | $68.01 | $554.1K | 3,819,831 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-19 | 2025-12-23 | 3,979 | $66.67 | $265.3K | 3,827,978 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2025-12-19 | 2025-12-23 | 5,281 | $67.97 | $358.9K | 37,683 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2025-12-19 | 2025-12-23 | 1,960 | $68.39 | $134.0K | 35,723 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2025-12-19 | 2025-12-23 | 2,799 | $66.63 | $186.5K | 42,964 | SEC↗ |
| Waddill William D. | Director | S Sale | 2025-12-19 | 2025-12-23 | 500 | $68.53 | $34.3K | 56,563 | SEC↗ |
| Waddill William D. | Director | S Sale | 2025-12-19 | 2025-12-23 | 2,416 | $66.66 | $161.1K | 62,514 | SEC↗ |
| Waddill William D. | Director | S Sale | 2025-12-19 | 2025-12-23 | 5,451 | $68.01 | $370.7K | 57,063 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-19 | 46,287 | $63.55 | $2.94M | 3,870,670 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-19 | 1,981 | $66.30 | $131.3K | 3,831,957 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-19 | 982 | $65.53 | $64.4K | 3,833,938 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-19 | 35,750 | $64.51 | $2.31M | 3,834,920 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 6,661 | $64.29 | $428.2K | 3,922,644 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 8,416 | $60.51 | $509.3K | 3,962,839 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 10,963 | $61.25 | $671.5K | 3,951,876 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 14,095 | $62.12 | $875.6K | 3,937,781 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 8,476 | $62.94 | $533.5K | 3,929,305 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 1,000 | $64.96 | $65.0K | 3,921,644 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 1,300 | $65.77 | $85.5K | 3,920,344 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 166 | $66.77 | $11.1K | 3,920,178 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-16 | 2025-12-16 | 3,221 | $67.87 | $218.6K | 3,916,957 | SEC↗ |
| Waddill William D. | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 64,930 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 43,600 | SEC↗ |
| INGRAM DOUGLAS S | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 46,215 | SEC↗ |
| Vakiener Victoria | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 45,763 | SEC↗ |
| PERRY MICHAEL S | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 123,059 | SEC↗ |
| Lu Hongbo | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 54,982 | SEC↗ |
| Ferrari Mauro | Director | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 76,583 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-15 | 2025-12-16 | 100,532 | $68.67 | $6.90M | 4,000,723 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-15 | 2025-12-16 | 21,321 | $69.28 | $1.48M | 3,979,402 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-12-15 | 2025-12-16 | 8,147 | $69.96 | $570.0K | 3,971,255 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2025-12-12 | 2025-12-16 | 180,000 | — | $0 | 4,101,255 | SEC↗ |
| PERRY MICHAEL S | Director | S Sale | 2025-12-05 | 2025-12-09 | 16,250 | $61.03 | $991.7K | 115,240 | SEC↗ |
| Ferrari Mauro | Director | S Sale | 2025-11-28 | 2025-12-01 | 8,750 | $56.39 | $493.4K | 68,764 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2025-10-01 | 2025-10-03 | 20,000 | $35.00 | $700.0K | 212,122 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2025-09-12 | 2025-09-16 | 15,000 | $30.00 | $450.0K | 232,122 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2025-09-02 | 2025-09-04 | 15,000 | $25.00 | $375.0K | 247,122 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2025-08-15 | 2025-08-15 | 9,389 | $20.00 | $187.8K | 262,122 | SEC↗ |
| Hamilton James C | Chief Medical Officer | S Sale | 2025-08-13 | 2025-08-15 | 611 | $20.00 | $12.2K | 271,511 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-04-11 | 2025-04-11 | 50,800 | $11.49 | $583.7K | 3,921,255 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-04-10 | 2025-04-11 | 50,000 | $10.87 | $543.5K | 3,972,055 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-04-09 | 2025-04-11 | 35,305 | $9.93 | $350.6K | 4,027,072 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-04-09 | 2025-04-11 | 3,400 | $10.75 | $36.5K | 4,023,672 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-04-09 | 2025-04-11 | 1,617 | $11.76 | $19.0K | 4,022,055 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2025-03-13 | 2025-03-17 | 340,000 | — | $0 | 4,113,802 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-03-13 | 2025-03-17 | 51,425 | $15.07 | $775.0K | 4,062,377 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-05 | 133,333 | $17.02 | $2.27M | 3,773,802 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2025-03-04 | 2025-03-05 | 133,333 | $7.75 | $1.03M | 4,073,802 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2025-03-03 | 2025-03-05 | 166,667 | — | $0 | 185,059 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2025-03-03 | 2025-03-05 | 133,333 | — | $0 | 51,726 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 166,667 | $18.03 | $3.01M | 3,907,135 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2025-03-03 | 2025-03-05 | 166,667 | $7.75 | $1.29M | 3,940,469 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2025-02-07 | 2025-02-10 | 9,550 | $20.10 | $192.0K | 3,773,802 | SEC↗ |
| INGRAM DOUGLAS S | Director | A Award | 2025-02-06 | 2025-02-07 | 38,396 | $20.09 | $771.4K | 38,396 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2025-01-23 | 2025-01-27 | 959 | $21.00 | $20.1K | 35,781 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2025-01-07 | 2025-01-07 | 8,000 | $19.70 | $157.6K | 465,433 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2025-01-07 | 2025-01-07 | 10,000 | $19.69 | $196.9K | 455,433 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2025-01-07 | 2025-01-07 | 8,000 | $19.69 | $157.5K | 527,201 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2025-01-06 | 2025-01-07 | 9,402 | $20.10 | $189.0K | 473,433 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2025-01-06 | 2025-01-07 | 17,765 | $19.68 | $349.6K | 482,835 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2025-01-06 | 2025-01-07 | 9,526 | $20.10 | $191.5K | 535,201 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2025-01-06 | 2025-01-07 | 19,658 | $19.69 | $387.1K | 544,727 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | S Sale | 2025-01-06 | 2025-01-07 | 21,758 | $19.68 | $428.2K | 283,093 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | S Sale | 2025-01-06 | 2025-01-07 | 10,971 | $20.11 | $220.6K | 272,122 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | A Award | 2025-01-04 | 2025-01-07 | 100,000 | — | $0 | 500,600 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | A Award | 2025-01-04 | 2025-01-07 | 100,000 | — | $0 | 564,385 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | A Award | 2025-01-04 | 2025-01-07 | 100,000 | — | $0 | 304,851 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2025-01-02 | 2025-01-06 | 11,520 | $19.05 | $219.5K | 3,764,252 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2024-12-27 | 2024-12-30 | 2,850 | $20.00 | $57.0K | 36,740 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-12-23 | 2024-12-23 | 12,563 | $19.59 | $246.1K | 3,775,772 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2024-12-18 | 2024-12-20 | 100,000 | — | $0 | 3,788,335 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-12-18 | 2024-12-20 | 5,799 | $22.12 | $128.3K | 3,688,335 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-12-18 | 2024-12-20 | 8,260 | $21.74 | $179.6K | 3,694,134 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-12-18 | 2024-12-20 | 12,653 | $20.52 | $259.6K | 3,702,394 | SEC↗ |
| Lu Hongbo | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 47,163 | SEC↗ |
| PERRY MICHAEL S | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 131,490 | SEC↗ |
| Ferrari Mauro | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 77,514 | SEC↗ |
| Waddill William D. | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 57,111 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 39,590 | SEC↗ |
| Vakiener Victoria | Director | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 37,944 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2024-12-17 | 2024-12-18 | 547 | $22.04 | $12.1K | 124,167 | SEC↗ |
| Waddill William D. | Director | S Sale | 2024-12-17 | 2024-12-18 | 3,747 | $22.04 | $82.6K | 40,378 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2024-12-16 | 2024-12-18 | 8,994 | $21.91 | $197.1K | 21,211 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2024-12-16 | 2024-12-18 | 5,000 | $21.90 | $109.5K | 124,714 | SEC↗ |
| Waddill William D. | Director | S Sale | 2024-12-16 | 2024-12-18 | 3,748 | $21.90 | $82.1K | 44,125 | SEC↗ |
| Oliver Tracie | Chief Commercial Officer | S Sale | 2024-07-02 | 2024-07-03 | 9,394 | $25.28 | $237.5K | 127,107 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2024-05-02 | 2024-05-06 | 1,799 | $23.31 | $41.9K | 30,205 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | S Sale | 2024-04-01 | 2024-04-03 | 6,000 | $28.03 | $168.2K | 204,851 | SEC↗ |
| Lu Hongbo | Director | P Buy | 2024-03-20 | 2024-03-20 | 1,000 | $27.50 | $27.5K | 33,680 | SEC↗ |
| Lu Hongbo | Director | P Buy | 2024-03-19 | 2024-03-20 | 1,000 | $28.00 | $28.0K | 32,680 | SEC↗ |
| Lu Hongbo | Director | P Buy | 2024-03-18 | 2024-03-20 | 1,000 | $27.49 | $27.5K | 31,680 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2024-03-06 | 2024-03-08 | 40,000 | $35.19 | $1.41M | 400,600 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2024-01-31 | 2024-02-02 | 57,499 | — | $0 | 351,726 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-01-31 | 2024-02-02 | 37,769 | $32.16 | $1.21M | 3,734,778 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-01-31 | 2024-02-02 | 19,730 | $32.71 | $645.4K | 3,715,048 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2024-01-31 | 2024-02-02 | 57,499 | $14.54 | $836.0K | 3,772,547 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | S Sale | 2024-01-12 | 2024-01-17 | 3,702 | $37.37 | $138.3K | 210,851 | SEC↗ |
| Hamilton James C | Chief Discovery/Trans Medici | S Sale | 2024-01-12 | 2024-01-17 | 4,238 | $36.47 | $154.6K | 214,553 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2024-01-11 | 2024-01-16 | 1,100 | $38.84 | $42.7K | 32,001 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2024-01-11 | 2024-01-16 | 3,620 | $37.87 | $137.1K | 33,101 | SEC↗ |
| Ferrari Mauro | Director | S Sale | 2024-01-11 | 2024-01-16 | 2,147 | $37.80 | $81.2K | 61,778 | SEC↗ |
| Ferrari Mauro | Director | S Sale | 2024-01-11 | 2024-01-16 | 1,000 | $38.63 | $38.6K | 60,778 | SEC↗ |
| Waddill William D. | Director | S Sale | 2024-01-11 | 2024-01-16 | 2,634 | $37.81 | $99.6K | 49,170 | SEC↗ |
| Waddill William D. | Director | S Sale | 2024-01-11 | 2024-01-16 | 1,300 | $38.59 | $50.2K | 47,870 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2024-01-11 | 2024-01-16 | 1,811 | $37.76 | $68.4K | 130,811 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2024-01-11 | 2024-01-16 | 1,100 | $38.55 | $42.4K | 129,711 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-05 | 2024-01-05 | 8,200 | $34.99 | $286.9K | 477,126 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-05 | 2024-01-05 | 1,900 | $33.99 | $64.6K | 485,326 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-05 | 2024-01-05 | 12,741 | $35.65 | $454.2K | 464,385 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-05 | 2024-01-05 | 12,343 | $35.65 | $440.0K | 228,791 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-05 | 2024-01-05 | 1,800 | $34.00 | $61.2K | 249,134 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-05 | 2024-01-05 | 8,000 | $34.94 | $279.5K | 241,134 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-05 | 2024-01-05 | 10,000 | $35.00 | $350.0K | 218,791 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2024-01-05 | 2024-01-08 | 800 | $34.11 | $27.3K | 206,000 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2024-01-05 | 2024-01-08 | 3,100 | $35.03 | $108.6K | 202,900 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2024-01-05 | 2024-01-08 | 4,403 | $35.64 | $156.9K | 198,497 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2024-01-05 | 2024-01-08 | 1,400 | $34.04 | $47.7K | 455,304 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2024-01-05 | 2024-01-08 | 8,904 | $35.65 | $317.4K | 440,600 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2024-01-05 | 2024-01-08 | 5,800 | $34.97 | $202.8K | 449,504 | SEC↗ |
| Oliver Tracie | Chief Commercial Officer | S Sale | 2024-01-05 | 2024-01-08 | 74 | $33.89 | $2.5K | 136,501 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-04 | 2024-01-05 | 1,600 | $32.63 | $52.2K | 402,226 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | A Award | 2024-01-04 | 2024-01-05 | 85,000 | — | $0 | 487,226 | SEC↗ |
| Hamilton James C | Other | A Award | 2024-01-04 | 2024-01-05 | 75,000 | — | $0 | 250,934 | SEC↗ |
| San Martin Javier | Chief Medical Officer | A Award | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 206,800 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | A Award | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 456,704 | SEC↗ |
| Oliver Tracie | Chief Commercial Officer | A Award | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 136,575 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-03 | 2024-01-05 | 1,700 | $32.65 | $55.5K | 403,826 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-03 | 2024-01-05 | 400 | $33.41 | $13.4K | 405,526 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-03 | 2024-01-05 | 2,800 | $32.52 | $91.1K | 405,926 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2024-01-03 | 2024-01-05 | 3,849 | $31.83 | $122.5K | 408,726 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-03 | 2024-01-05 | 3,500 | $31.81 | $111.3K | 178,734 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-03 | 2024-01-05 | 2,300 | $32.52 | $74.8K | 176,434 | SEC↗ |
| Hamilton James C | Other | S Sale | 2024-01-03 | 2024-01-05 | 500 | $33.30 | $16.6K | 175,934 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-01-02 | 2024-01-04 | 5,318 | $31.25 | $166.2K | 3,715,048 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2024-01-02 | 2024-01-04 | 4,634 | $30.74 | $142.4K | 3,720,366 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-12-20 | 2023-12-22 | 12,000 | $28.54 | $342.5K | 3,725,000 | SEC↗ |
| Waddill William D. | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 51,804 | SEC↗ |
| GIVEN DOUGLAS B | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 132,622 | SEC↗ |
| Vakiener Victoria | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 36,721 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 22,854 | SEC↗ |
| PERRY MICHAEL S | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 114,754 | SEC↗ |
| Ferrari Mauro | Director | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 65,825 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2023-11-20 | 2023-11-22 | 4,942 | $29.00 | $143.3K | 131,800 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2023-11-20 | 2023-11-22 | 14,758 | $28.73 | $424.0K | 136,742 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-10-25 | 2023-10-27 | 24,338 | $24.21 | $589.2K | 3,737,000 | SEC↗ |
| Vakiener Victoria | Director | S Sale | 2023-09-28 | 2023-10-02 | 1,550 | $26.33 | $40.8K | 21,734 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2023-09-18 | 2023-09-20 | 57,555 | — | $0 | 409,225 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-09-18 | 2023-09-20 | 26,232 | $28.27 | $741.6K | 3,761,338 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2023-09-18 | 2023-09-20 | 57,755 | $4.75 | $274.3K | 3,819,093 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-09-18 | 2023-09-20 | 31,523 | $28.00 | $882.6K | 3,787,570 | SEC↗ |
| Oliver Tracie | Chief Commercial Officer | S Sale | 2023-07-03 | 2023-07-06 | 8,925 | $35.31 | $315.1K | 61,575 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-06-30 | 2023-07-05 | 3,000 | $35.53 | $106.6K | 188,484 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2023-06-27 | 2023-06-29 | 15,000 | $36.20 | $543.0K | 381,704 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2023-05-05 | 2023-05-08 | 6,500 | $40.90 | $265.9K | 117,635 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2023-05-04 | 2023-05-05 | 50,000 | — | $0 | 466,980 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2023-05-04 | 2023-05-05 | 50,000 | $2.01 | $100.5K | 3,811,338 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-05-04 | 2023-05-05 | 25,992 | $40.02 | $1.04M | 3,761,338 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-05-04 | 2023-05-05 | 24,008 | $38.97 | $935.6K | 3,787,330 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2023-05-03 | 2023-05-05 | 54,928 | — | $0 | 516,980 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2023-05-03 | 2023-05-05 | 54,928 | $2.01 | $110.4K | 3,816,266 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2023-05-03 | 2023-05-05 | 54,928 | $39.14 | $2.15M | 3,761,338 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | S Sale | 2023-03-03 | 2023-03-06 | 11,350 | $32.65 | $370.6K | 7,867 | SEC↗ |
| GIVEN DOUGLAS B | Director | S Sale | 2023-02-27 | 2023-03-01 | 875 | $32.62 | $28.5K | 13,000 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| GIVEN DOUGLAS B | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| PERRY MICHAEL S | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| Vakiener Victoria | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| De Backer Marianne | Director | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| Ferrari Mauro | Director | A Award deriv | 2023-01-10 | 2023-01-12 | 4,593 | — | $0 | 4,593 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 19,217 | SEC↗ |
| Waddill William D. | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 36,817 | SEC↗ |
| GIVEN DOUGLAS B | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 124,135 | SEC↗ |
| PERRY MICHAEL S | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 99,767 | SEC↗ |
| Vakiener Victoria | Director | D To issuer | 2023-01-10 | 2023-01-11 | 1,764 | — | $0 | 15,417 | SEC↗ |
| Vakiener Victoria | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 23,284 | SEC↗ |
| De Backer Marianne | Director | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 31,267 | SEC↗ |
| Ferrari Mauro | Director | A Award | 2023-01-10 | 2023-01-12 | 7,867 | — | $0 | 50,838 | SEC↗ |
| Waddill William D. | Director | S Sale | 2023-01-09 | 2023-01-11 | 3,200 | $30.00 | $96.0K | 28,950 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-05 | 2023-01-06 | 6,573 | $37.40 | $245.8K | 191,484 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-05 | 2023-01-06 | 7,230 | $37.40 | $270.4K | 198,057 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-05 | 2023-01-06 | 7,500 | $37.39 | $280.4K | 420,875 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-05 | 2023-01-06 | 7,500 | $37.39 | $280.4K | 413,375 | SEC↗ |
| Hamilton James C | Other | A Award | 2023-01-04 | 2023-01-05 | 60,000 | — | $0 | 205,287 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | A Award | 2023-01-04 | 2023-01-05 | 65,000 | — | $0 | 428,375 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | A Award | 2023-01-04 | 2023-01-05 | 60,000 | — | $0 | 396,704 | SEC↗ |
| San Martin Javier | Chief Medical Officer | A Award | 2023-01-04 | 2023-01-05 | 60,000 | — | $0 | 151,500 | SEC↗ |
| Oliver Tracie | Chief Commercial Officer | A Award | 2023-01-04 | 2023-01-05 | 500 | — | $0 | 70,500 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 300 | $39.74 | $11.9K | 151,294 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 2,837 | $38.53 | $109.3K | 151,594 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 300 | $39.56 | $11.9K | 145,534 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 247 | $40.52 | $10.0K | 145,287 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 136 | $40.54 | $5.5K | 151,158 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 1,642 | $37.49 | $61.6K | 149,516 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 3,682 | $38.52 | $141.8K | 145,834 | SEC↗ |
| Hamilton James C | Other | S Sale | 2023-01-03 | 2023-01-05 | 1,194 | $37.46 | $44.7K | 154,431 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 70 | $40.80 | $2.9K | 372,125 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 500 | $39.74 | $19.9K | 372,195 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 5,527 | $38.54 | $213.0K | 372,695 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 2,894 | $37.58 | $108.8K | 369,231 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 2,653 | $37.53 | $99.6K | 378,222 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 270 | $40.53 | $10.9K | 363,375 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 300 | $39.55 | $11.9K | 363,645 | SEC↗ |
| O'Brien Patrick | COO and General Counsel | S Sale | 2023-01-03 | 2023-01-05 | 5,286 | $38.58 | $203.9K | 363,945 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2022-12-29 | 2022-12-30 | 30,625 | $40.00 | $1.23M | 336,704 | SEC↗ |
| O'Brien Patrick | General Counsel | M Exercise deriv | 2022-12-21 | 2022-12-22 | 32,000 | — | $0 | 0 | SEC↗ |
| O'Brien Patrick | General Counsel | M Exercise | 2022-12-21 | 2022-12-22 | 32,000 | $6.15 | $196.8K | 380,875 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2022-12-20 | 2022-12-20 | 234,025 | — | $0 | 3,720,714 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | A Award | 2022-12-16 | 2022-12-20 | 18,375 | — | $0 | 3,486,689 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2022-11-21 | 2022-11-22 | 19,300 | $29.98 | $578.6K | 91,700 | SEC↗ |
| San Martin Javier | Chief Medical Officer | S Sale | 2022-11-21 | 2022-11-22 | 200 | $30.62 | $6.1K | 91,500 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2022-09-27 | 2022-09-29 | 1,542 | $31.21 | $48.1K | 3,468,314 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2022-09-27 | 2022-09-29 | 39,082 | $30.77 | $1.20M | 3,469,856 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | D To issuer | 2022-07-08 | 2022-07-12 | 551,197 | — | $0 | 3,508,938 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2022-07-07 | 2022-07-11 | 2,501 | — | $0 | 612,532 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2022-07-07 | 2022-07-11 | 2,501 | $14.54 | $36.4K | 4,060,135 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2022-02-11 | 2022-02-14 | 146,388 | — | $0 | 615,033 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2022-02-11 | 2022-02-14 | 146,388 | $5.19 | $759.8K | 4,204,022 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2022-02-11 | 2022-02-14 | 40,853 | $53.11 | $2.17M | 4,163,169 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2022-02-11 | 2022-02-14 | 42,153 | $52.28 | $2.20M | 4,121,016 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2022-02-11 | 2022-02-14 | 61,482 | $50.90 | $3.13M | 4,059,534 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | S Sale | 2022-02-11 | 2022-02-14 | 1,900 | $50.51 | $96.0K | 4,057,634 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise deriv | 2022-01-07 | 2022-01-07 | 11,806 | — | $0 | 761,421 | SEC↗ |
| De Backer Marianne | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 23,400 | SEC↗ |
| Ferrari Mauro | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 42,971 | SEC↗ |
| GIVEN DOUGLAS B | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 116,268 | SEC↗ |
| OLUKOTUN ADEOYE Y | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 11,350 | SEC↗ |
| PERRY MICHAEL S | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 91,900 | SEC↗ |
| Waddill William D. | Director | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 32,150 | SEC↗ |
| Anzalone Christopher Richard | Chief Executive Officer | M Exercise | 2022-01-07 | 2022-01-07 | 11,806 | $5.19 | $61.3K | 4,057,634 | SEC↗ |
| Hamilton James C | Other | S Sale | 2022-01-05 | 2022-01-06 | 2,290 | $60.51 | $138.6K | 159,585 | SEC↗ |
| Hamilton James C | Other | S Sale | 2022-01-05 | 2022-01-06 | 2,100 | $61.84 | $129.9K | 157,485 | SEC↗ |
| Hamilton James C | Other | S Sale | 2022-01-05 | 2022-01-06 | 1,100 | $62.64 | $68.9K | 156,385 | SEC↗ |
| Hamilton James C | Other | S Sale | 2022-01-05 | 2022-01-06 | 700 | $63.68 | $44.6K | 155,685 | SEC↗ |
| Hamilton James C | Other | S Sale | 2022-01-05 | 2022-01-06 | 60 | $64.35 | $3.9K | 155,625 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2022-01-05 | 2022-01-06 | 16,528 | $62.00 | $1.02M | 471,569 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2022-01-05 | 2022-01-06 | 3,778 | $63.17 | $238.7K | 467,791 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2022-01-05 | 2022-01-06 | 3,786 | $63.95 | $242.1K | 464,005 | SEC↗ |
| Myszkowski Kenneth Allen | Chief Financial Officer | S Sale | 2022-01-05 | 2022-01-06 | 15,908 | $60.50 | $962.4K | 488,097 | SEC↗ |
| O'Brien Patrick | General Counsel | S Sale | 2022-01-05 | 2022-01-07 | 316 | $64.35 | $20.3K | 348,875 | SEC↗ |
| O'Brien Patrick | General Counsel | S Sale | 2022-01-05 | 2022-01-07 | 12,434 | $60.49 | $752.1K | 368,941 | SEC↗ |
| O'Brien Patrick | General Counsel | S Sale | 2022-01-05 | 2022-01-07 | 4,400 | $63.75 | $280.5K | 349,191 | SEC↗ |